MNOV
MediciNova Inc
2.60$
-2.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -55.4% | -97.9% | +10,755,800.0% | -100.0% | – | – | – | – | – | – | -100,077.3% | – | – | – | – | – | – | -8.4% | +23.0% | +23.2% | +145.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +678.3% | +22.4% | -10.7% | -11.6% | +11.9% | +0.9% | -89.5% | -3.7% | -2.6% | +0.4% | -3.5% | -0.1% | +0.0% | +2,147.4% | -0.9% | -13.3% | +74.4% | -19.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.2% | – | -117.0% | – | – | – | – | – | – | – | -100.5% | – | – | – | – | – | – | -55.9% | +543.2% | -75.6% | +2,417.3% | – | |
| – | -33.5% | +52.3% | -0.4% | +41.4% | -8.7% | +43.6% | -17.0% | +71.8% | -91.0% | +661.8% | -10.3% | -21.5% | +58.9% | -31.6% | +75.8% | +1.8% | -6.5% | -3.0% | +16.6% | -15.4% | -11.6% | +14.4% | +19.7% | -2.4% | -1.4% | -39.8% | +16.7% | -57.2% | +134.5% | -0.2% | -6.3% | +15.0% | +7.8% | -8.8% | +17.2% | -25.3% | +11.1% | +74,586.3% | -99.9% | – | |
| – | -56.6% | +150.0% | -10.1% | +32.3% | -10.8% | +33.6% | -32.7% | +130.5% | -94.0% | +1,104.4% | -18.8% | -45.0% | -73.6% | +323.4% | +38.1% | -35.4% | -34.6% | +110.7% | -13.3% | -16.2% | -78.2% | +282.3% | +17.2% | -5.5% | -16.8% | +23.9% | +5.6% | -14.1% | -34.8% | +53.8% | +3.7% | +2.8% | -7.2% | +2.5% | +5.6% | +27.2% | -11.6% | +102,245.2% | -99.9% | – | |
| – | -49.4% | +109.9% | -7.2% | +35.2% | -10.1% | +37.0% | -27.1% | +106.7% | -93.0% | +911.6% | -16.0% | -36.7% | -15.9% | +31.5% | +54.2% | -17.3% | -19.2% | +39.4% | +2.6% | -15.5% | -42.4% | +62.7% | +19.9% | -4.7% | -17.1% | -8.3% | +11.4% | -34.9% | +15.7% | +26.2% | -2.9% | +8.6% | -3.9% | +0.8% | +13.2% | -6.5% | -7.2% | -9.4% | +0.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +144.4% | +178.0% | +50.7% | -88.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -126.1% | – | -50.0% | +1.2% | -85,406.4% | – | – | -12.8% | +2.6% | -17,933.8% | – | – | – | – | – | – | – | – | – | – | – | -1,018.8% | – | – | – | -1,720.8% | – | – | – | -1,362.3% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.